Does ViroPharma have a bio-defense program?
Yes. We are working with the government and others in the area of biodefense and initiated a program to discover and advance potential antiviral product candidates that address National Institutes of Health “category A viruses,” which include smallpox virus and viral hemorrhagic fever viruses (Ebola, Lassa and Rift Valley fever viruses). Last fall, we applied to be considered for government funding to help defray the costs of advancing this program and hope to be moving ahead in this program the second half of this year.
